変形性関節症の鎮痛剤世界市場の発展状況と動向 2024-2030

QY Research > レポート一覧 > 薬品及びサプリメント > 変形性関節症の鎮痛剤世界市場の発展状況と動向 2024-2030

英文タイトル： Global Osteoarthritis Pain Medicine Market Insights, Forecast to 2030

レポートID：286067
発表時期：2024-04-24
訪問回数：827
ページ数：116
レポート形式：PDF
レポート言語：英語、日本語
グラフ数：148
レポートカテゴリ：薬品及びサプリメント

販売価格（消費税別）

個人版
詳細
マルチユーザー版
詳細
企業版
詳細

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10％消費税。

英語版

日本語版

英語と日本語版

価格表記: USDを日本円(税抜)に換算，本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10％消費税。

お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合，注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。但し、日本語版が必要な場合は、受注後8～10営業日となります。お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

概要

本報告書は、変形性関節症の鎮痛剤の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に変形性関節症の鎮痛剤市場を分類しています。

本レポートでは世界の変形性関節症の鎮痛剤市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Pfizer、Johnson and Johnson、GlaxoSmithKline、Bayer、Eli Lilly、Novartis、Sanofi、Horizon Pharma、Abbott、Mylan、Daiichi Sankyo、TEVA、Almatica Pharma、Astellas Pharma、Tide Pharmaceutical、Iroko Pharmaceuticals、Hengrui Pharmaceutical、Abiogen Pharma

レポートは変形性関節症の鎮痛剤の主要生産者を調査し、主要地域や国の消費状況も提供します。変形性関節症の鎮痛剤の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。

タイプ別市場セグメント：
Oral
Injection
External

用途別の市場セグメント：
Medical Care
Personal Care

本レポートの詳細内容
本レポートは、世界の変形性関節症の鎮痛剤市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて変形性関節症の鎮痛剤市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。

一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の変形性関節症の鎮痛剤生産量、成長率、市場シェアを調査している。

二. 消費面では、変形性関節症の鎮痛剤の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの変形性関節症の鎮痛剤売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の変形性関節症の鎮痛剤市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本変形性関節症の鎮痛剤のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要

第1章：変形性関節症の鎮痛剤のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章：変形性関節症の鎮痛剤の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける変形性関節症の鎮痛剤の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章変形性関節症の鎮痛剤メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：変形性関節症の鎮痛剤の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：変形性関節症の鎮痛剤の主要メーカーの概要を提供し、製品の説明と仕様、変形性関節症の鎮痛剤の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：変形性関節症の鎮痛剤の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

概要

Drugs for Osteoarthritis Pain market, the main role of osteoarthritis pain drugs is to relieve pain, and cannot slow the progress of osteoarthritis.

The global Osteoarthritis Pain Medicine market is projected to grow from US$ 9599.7 million in 2024 to US$ 11730 million by 2030, at a Compound Annual Growth Rate (CAGR) of 3.4% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Osteoarthritis Pain Medicine, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Osteoarthritis Pain Medicine, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Osteoarthritis Pain Medicine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Osteoarthritis Pain Medicine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Osteoarthritis Pain Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Osteoarthritis Pain Medicine sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Johnson and Johnson, GlaxoSmithKline, Bayer, Eli Lilly, Novartis, Sanofi, Horizon Pharma and Abbott, etc.

Market Segmentation
By Company
Pfizer
Johnson and Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma

Segment by Type
Oral
Injection
External

Segment by Application
Medical Care
Personal Care

Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Osteoarthritis Pain Medicine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Osteoarthritis Pain Medicine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Osteoarthritis Pain Medicine sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

総目録

1 Study Coverage
1.1 Osteoarthritis Pain Medicine Product Introduction
1.2 Market by Type
1.2.1 Global Osteoarthritis Pain Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Market by Application
1.3.1 Global Osteoarthritis Pain Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Executive Summary
2.1 Global Osteoarthritis Pain Medicine Sales Estimates and Forecasts 2019-2030
2.2 Global Osteoarthritis Pain Medicine Revenue by Region
2.2.1 Global Osteoarthritis Pain Medicine Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Osteoarthritis Pain Medicine Revenue by Region (2019-2024)
2.2.3 Global Osteoarthritis Pain Medicine Revenue by Region (2025-2030)
2.2.4 Global Osteoarthritis Pain Medicine Revenue Market Share by Region (2019-2030)
2.3 Global Osteoarthritis Pain Medicine Sales Estimates and Forecasts 2019-2030
2.4 Global Osteoarthritis Pain Medicine Sales by Region
2.4.1 Global Osteoarthritis Pain Medicine Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Osteoarthritis Pain Medicine Sales by Region (2019-2024)
2.4.3 Global Osteoarthritis Pain Medicine Sales by Region (2025-2030)
2.4.4 Global Osteoarthritis Pain Medicine Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America

3 Competition by Manufactures
3.1 Global Osteoarthritis Pain Medicine Sales by Manufacturers
3.1.1 Global Osteoarthritis Pain Medicine Sales by Manufacturers (2019-2024)
3.1.2 Global Osteoarthritis Pain Medicine Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Osteoarthritis Pain Medicine in 2023
3.2 Global Osteoarthritis Pain Medicine Revenue by Manufacturers
3.2.1 Global Osteoarthritis Pain Medicine Revenue by Manufacturers (2019-2024)
3.2.2 Global Osteoarthritis Pain Medicine Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Osteoarthritis Pain Medicine Revenue in 2023
3.3 Global Key Players of Osteoarthritis Pain Medicine, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Osteoarthritis Pain Medicine Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Osteoarthritis Pain Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Osteoarthritis Pain Medicine, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Osteoarthritis Pain Medicine, Product Offered and Application
3.8 Global Key Manufacturers of Osteoarthritis Pain Medicine, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Osteoarthritis Pain Medicine Sales by Type
4.1.1 Global Osteoarthritis Pain Medicine Historical Sales by Type (2019-2024)
4.1.2 Global Osteoarthritis Pain Medicine Forecasted Sales by Type (2025-2030)
4.1.3 Global Osteoarthritis Pain Medicine Sales Market Share by Type (2019-2030)
4.2 Global Osteoarthritis Pain Medicine Revenue by Type
4.2.1 Global Osteoarthritis Pain Medicine Historical Revenue by Type (2019-2024)
4.2.2 Global Osteoarthritis Pain Medicine Forecasted Revenue by Type (2025-2030)
4.2.3 Global Osteoarthritis Pain Medicine Revenue Market Share by Type (2019-2030)
4.3 Global Osteoarthritis Pain Medicine Price by Type
4.3.1 Global Osteoarthritis Pain Medicine Price by Type (2019-2024)
4.3.2 Global Osteoarthritis Pain Medicine Price Forecast by Type (2025-2030)

5 Market Size by Application
5.1 Global Osteoarthritis Pain Medicine Sales by Application
5.1.1 Global Osteoarthritis Pain Medicine Historical Sales by Application (2019-2024)
5.1.2 Global Osteoarthritis Pain Medicine Forecasted Sales by Application (2025-2030)
5.1.3 Global Osteoarthritis Pain Medicine Sales Market Share by Application (2019-2030)
5.2 Global Osteoarthritis Pain Medicine Revenue by Application
5.2.1 Global Osteoarthritis Pain Medicine Historical Revenue by Application (2019-2024)
5.2.2 Global Osteoarthritis Pain Medicine Forecasted Revenue by Application (2025-2030)
5.2.3 Global Osteoarthritis Pain Medicine Revenue Market Share by Application (2019-2030)
5.3 Global Osteoarthritis Pain Medicine Price by Application
5.3.1 Global Osteoarthritis Pain Medicine Price by Application (2019-2024)
5.3.2 Global Osteoarthritis Pain Medicine Price Forecast by Application (2025-2030)

6 US & Canada
6.1 US & Canada Osteoarthritis Pain Medicine Market Size by Type
6.1.1 US & Canada Osteoarthritis Pain Medicine Sales by Type (2019-2030)
6.1.2 US & Canada Osteoarthritis Pain Medicine Revenue by Type (2019-2030)
6.2 US & Canada Osteoarthritis Pain Medicine Market Size by Application
6.2.1 US & Canada Osteoarthritis Pain Medicine Sales by Application (2019-2030)
6.2.2 US & Canada Osteoarthritis Pain Medicine Revenue by Application (2019-2030)
6.3 US & Canada Osteoarthritis Pain Medicine Market Size by Country
6.3.1 US & Canada Osteoarthritis Pain Medicine Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Osteoarthritis Pain Medicine Sales by Country (2019-2030)
6.3.3 US & Canada Osteoarthritis Pain Medicine Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada

7 Europe
7.1 Europe Osteoarthritis Pain Medicine Market Size by Type
7.1.1 Europe Osteoarthritis Pain Medicine Sales by Type (2019-2030)
7.1.2 Europe Osteoarthritis Pain Medicine Revenue by Type (2019-2030)
7.2 Europe Osteoarthritis Pain Medicine Market Size by Application
7.2.1 Europe Osteoarthritis Pain Medicine Sales by Application (2019-2030)
7.2.2 Europe Osteoarthritis Pain Medicine Revenue by Application (2019-2030)
7.3 Europe Osteoarthritis Pain Medicine Market Size by Country
7.3.1 Europe Osteoarthritis Pain Medicine Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Osteoarthritis Pain Medicine Sales by Country (2019-2030)
7.3.3 Europe Osteoarthritis Pain Medicine Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia

8 China
8.1 China Osteoarthritis Pain Medicine Market Size
8.1.1 China Osteoarthritis Pain Medicine Sales (2019-2030)
8.1.2 China Osteoarthritis Pain Medicine Revenue (2019-2030)
8.2 China Osteoarthritis Pain Medicine Market Size by Application
8.2.1 China Osteoarthritis Pain Medicine Sales by Application (2019-2030)
8.2.2 China Osteoarthritis Pain Medicine Revenue by Application (2019-2030)

9 Asia (excluding China)
9.1 Asia Osteoarthritis Pain Medicine Market Size by Type
9.1.1 Asia Osteoarthritis Pain Medicine Sales by Type (2019-2030)
9.1.2 Asia Osteoarthritis Pain Medicine Revenue by Type (2019-2030)
9.2 Asia Osteoarthritis Pain Medicine Market Size by Application
9.2.1 Asia Osteoarthritis Pain Medicine Sales by Application (2019-2030)
9.2.2 Asia Osteoarthritis Pain Medicine Revenue by Application (2019-2030)
9.3 Asia Osteoarthritis Pain Medicine Sales by Region
9.3.1 Asia Osteoarthritis Pain Medicine Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Osteoarthritis Pain Medicine Revenue by Region (2019-2030)
9.3.3 Asia Osteoarthritis Pain Medicine Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India

10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Osteoarthritis Pain Medicine Market Size by Type
10.1.1 Middle East, Africa and Latin America Osteoarthritis Pain Medicine Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Osteoarthritis Pain Medicine Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Osteoarthritis Pain Medicine Market Size by Application
10.2.1 Middle East, Africa and Latin America Osteoarthritis Pain Medicine Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Osteoarthritis Pain Medicine Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Osteoarthritis Pain Medicine Sales by Country
10.3.1 Middle East, Africa and Latin America Osteoarthritis Pain Medicine Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Osteoarthritis Pain Medicine Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Osteoarthritis Pain Medicine Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Information
11.1.2 Pfizer Overview
11.1.3 Pfizer Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Pfizer Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Pfizer Recent Developments
11.2 Johnson and Johnson
11.2.1 Johnson and Johnson Company Information
11.2.2 Johnson and Johnson Overview
11.2.3 Johnson and Johnson Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Johnson and Johnson Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Johnson and Johnson Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Information
11.3.2 GlaxoSmithKline Overview
11.3.3 GlaxoSmithKline Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 GlaxoSmithKline Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 GlaxoSmithKline Recent Developments
11.4 Bayer
11.4.1 Bayer Company Information
11.4.2 Bayer Overview
11.4.3 Bayer Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 Bayer Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bayer Recent Developments
11.5 Eli Lilly
11.5.1 Eli Lilly Company Information
11.5.2 Eli Lilly Overview
11.5.3 Eli Lilly Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Eli Lilly Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Eli Lilly Recent Developments
11.6 Novartis
11.6.1 Novartis Company Information
11.6.2 Novartis Overview
11.6.3 Novartis Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Novartis Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis Recent Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Overview
11.7.3 Sanofi Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Sanofi Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Sanofi Recent Developments
11.8 Horizon Pharma
11.8.1 Horizon Pharma Company Information
11.8.2 Horizon Pharma Overview
11.8.3 Horizon Pharma Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Horizon Pharma Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Horizon Pharma Recent Developments
11.9 Abbott
11.9.1 Abbott Company Information
11.9.2 Abbott Overview
11.9.3 Abbott Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Abbott Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Abbott Recent Developments
11.10 Mylan
11.10.1 Mylan Company Information
11.10.2 Mylan Overview
11.10.3 Mylan Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Mylan Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Mylan Recent Developments
11.11 Daiichi Sankyo
11.11.1 Daiichi Sankyo Company Information
11.11.2 Daiichi Sankyo Overview
11.11.3 Daiichi Sankyo Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 Daiichi Sankyo Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Daiichi Sankyo Recent Developments
11.12 TEVA
11.12.1 TEVA Company Information
11.12.2 TEVA Overview
11.12.3 TEVA Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 TEVA Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 TEVA Recent Developments
11.13 Almatica Pharma
11.13.1 Almatica Pharma Company Information
11.13.2 Almatica Pharma Overview
11.13.3 Almatica Pharma Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 Almatica Pharma Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Almatica Pharma Recent Developments
11.14 Astellas Pharma
11.14.1 Astellas Pharma Company Information
11.14.2 Astellas Pharma Overview
11.14.3 Astellas Pharma Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Astellas Pharma Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Astellas Pharma Recent Developments
11.15 Tide Pharmaceutical
11.15.1 Tide Pharmaceutical Company Information
11.15.2 Tide Pharmaceutical Overview
11.15.3 Tide Pharmaceutical Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Tide Pharmaceutical Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Tide Pharmaceutical Recent Developments
11.16 Iroko Pharmaceuticals
11.16.1 Iroko Pharmaceuticals Company Information
11.16.2 Iroko Pharmaceuticals Overview
11.16.3 Iroko Pharmaceuticals Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Iroko Pharmaceuticals Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Iroko Pharmaceuticals Recent Developments
11.17 Hengrui Pharmaceutical
11.17.1 Hengrui Pharmaceutical Company Information
11.17.2 Hengrui Pharmaceutical Overview
11.17.3 Hengrui Pharmaceutical Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.17.4 Hengrui Pharmaceutical Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Hengrui Pharmaceutical Recent Developments
11.18 Abiogen Pharma
11.18.1 Abiogen Pharma Company Information
11.18.2 Abiogen Pharma Overview
11.18.3 Abiogen Pharma Osteoarthritis Pain Medicine Sales, Price, Revenue and Gross Margin (2019-2024)
11.18.4 Abiogen Pharma Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Abiogen Pharma Recent Developments

12 Industry Chain and Sales Channels Analysis
12.1 Osteoarthritis Pain Medicine Industry Chain Analysis
12.2 Osteoarthritis Pain Medicine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Osteoarthritis Pain Medicine Production Mode & Process
12.4 Osteoarthritis Pain Medicine Sales and Marketing
12.4.1 Osteoarthritis Pain Medicine Sales Channels
12.4.2 Osteoarthritis Pain Medicine Distributors
12.5 Osteoarthritis Pain Medicine Customers

13 Market Dynamics
13.1 Osteoarthritis Pain Medicine Industry Trends
13.2 Osteoarthritis Pain Medicine Market Drivers
13.3 Osteoarthritis Pain Medicine Market Challenges
13.4 Osteoarthritis Pain Medicine Market Restraints

14 Key Findings in The Global Osteoarthritis Pain Medicine Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

表と図のリスト

List of Tables
    Table 1. Global Osteoarthritis Pain Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Oral
    Table 3. Major Manufacturers of Injection
    Table 4. Major Manufacturers of External
    Table 5. Global Osteoarthritis Pain Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Osteoarthritis Pain Medicine Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 7. Global Osteoarthritis Pain Medicine Revenue by Region (2019-2024) & (US$ Million)
    Table 8. Global Osteoarthritis Pain Medicine Revenue by Region (2025-2030) & (US$ Million)
    Table 9. Global Osteoarthritis Pain Medicine Revenue Market Share by Region (2019-2024)
    Table 10. Global Osteoarthritis Pain Medicine Revenue Market Share by Region (2025-2030)
    Table 11. Global Osteoarthritis Pain Medicine Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 12. Global Osteoarthritis Pain Medicine Sales by Region (2019-2024) & (K Units)
    Table 13. Global Osteoarthritis Pain Medicine Sales by Region (2025-2030) & (K Units)
    Table 14. Global Osteoarthritis Pain Medicine Sales Market Share by Region (2019-2024)
    Table 15. Global Osteoarthritis Pain Medicine Sales Market Share by Region (2025-2030)
    Table 16. Global Osteoarthritis Pain Medicine Sales by Manufacturers (2019-2024) & (K Units)
    Table 17. Global Osteoarthritis Pain Medicine Sales Share by Manufacturers (2019-2024)
    Table 18. Global Osteoarthritis Pain Medicine Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 19. Global Osteoarthritis Pain Medicine Revenue Share by Manufacturers (2019-2024)
    Table 20. Global Key Players of Osteoarthritis Pain Medicine, Industry Ranking, 2022 VS 2023 VS 2024
    Table 21. Osteoarthritis Pain Medicine Price by Manufacturers 2019-2024 (USD/Unit)
    Table 22. Global Osteoarthritis Pain Medicine Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Osteoarthritis Pain Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Osteoarthritis Pain Medicine as of 2023)
    Table 24. Global Key Manufacturers of Osteoarthritis Pain Medicine, Manufacturing Base Distribution and Headquarters
    Table 25. Global Key Manufacturers of Osteoarthritis Pain Medicine, Product Offered and Application
    Table 26. Global Key Manufacturers of Osteoarthritis Pain Medicine, Date of Enter into This Industry
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Osteoarthritis Pain Medicine Sales by Type (2019-2024) & (K Units)
    Table 29. Global Osteoarthritis Pain Medicine Sales by Type (2025-2030) & (K Units)
    Table 30. Global Osteoarthritis Pain Medicine Sales Share by Type (2019-2024)
    Table 31. Global Osteoarthritis Pain Medicine Sales Share by Type (2025-2030)
    Table 32. Global Osteoarthritis Pain Medicine Revenue by Type (2019-2024) & (US$ Million)
    Table 33. Global Osteoarthritis Pain Medicine Revenue by Type (2025-2030) & (US$ Million)
    Table 34. Global Osteoarthritis Pain Medicine Revenue Share by Type (2019-2024)
    Table 35. Global Osteoarthritis Pain Medicine Revenue Share by Type (2025-2030)
    Table 36. Osteoarthritis Pain Medicine Price by Type (2019-2024) & (USD/Unit)
    Table 37. Global Osteoarthritis Pain Medicine Price Forecast by Type (2025-2030) & (USD/Unit)
    Table 38. Global Osteoarthritis Pain Medicine Sales by Application (2019-2024) & (K Units)
    Table 39. Global Osteoarthritis Pain Medicine Sales by Application (2025-2030) & (K Units)
    Table 40. Global Osteoarthritis Pain Medicine Sales Share by Application (2019-2024)
    Table 41. Global Osteoarthritis Pain Medicine Sales Share by Application (2025-2030)
    Table 42. Global Osteoarthritis Pain Medicine Revenue by Application (2019-2024) & (US$ Million)
    Table 43. Global Osteoarthritis Pain Medicine Revenue by Application (2025-2030) & (US$ Million)
    Table 44. Global Osteoarthritis Pain Medicine Revenue Share by Application (2019-2024)
    Table 45. Global Osteoarthritis Pain Medicine Revenue Share by Application (2025-2030)
    Table 46. Osteoarthritis Pain Medicine Price by Application (2019-2024) & (USD/Unit)
    Table 47. Global Osteoarthritis Pain Medicine Price Forecast by Application (2025-2030) & (USD/Unit)
    Table 48. US & Canada Osteoarthritis Pain Medicine Sales by Type (2019-2024) & (K Units)
    Table 49. US & Canada Osteoarthritis Pain Medicine Sales by Type (2025-2030) & (K Units)
    Table 50. US & Canada Osteoarthritis Pain Medicine Revenue by Type (2019-2024) & (US$ Million)
    Table 51. US & Canada Osteoarthritis Pain Medicine Revenue by Type (2025-2030) & (US$ Million)
    Table 52. US & Canada Osteoarthritis Pain Medicine Sales by Application (2019-2024) & (K Units)
    Table 53. US & Canada Osteoarthritis Pain Medicine Sales by Application (2025-2030) & (K Units)
    Table 54. US & Canada Osteoarthritis Pain Medicine Revenue by Application (2019-2024) & (US$ Million)
    Table 55. US & Canada Osteoarthritis Pain Medicine Revenue by Application (2025-2030) & (US$ Million)
    Table 56. US & Canada Osteoarthritis Pain Medicine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 57. US & Canada Osteoarthritis Pain Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 58. US & Canada Osteoarthritis Pain Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 59. US & Canada Osteoarthritis Pain Medicine Sales by Country (2019-2024) & (K Units)
    Table 60. US & Canada Osteoarthritis Pain Medicine Sales by Country (2025-2030) & (K Units)
    Table 61. Europe Osteoarthritis Pain Medicine Sales by Type (2019-2024) & (K Units)
    Table 62. Europe Osteoarthritis Pain Medicine Sales by Type (2025-2030) & (K Units)
    Table 63. Europe Osteoarthritis Pain Medicine Revenue by Type (2019-2024) & (US$ Million)
    Table 64. Europe Osteoarthritis Pain Medicine Revenue by Type (2025-2030) & (US$ Million)
    Table 65. Europe Osteoarthritis Pain Medicine Sales by Application (2019-2024) & (K Units)
    Table 66. Europe Osteoarthritis Pain Medicine Sales by Application (2025-2030) & (K Units)
    Table 67. Europe Osteoarthritis Pain Medicine Revenue by Application (2019-2024) & (US$ Million)
    Table 68. Europe Osteoarthritis Pain Medicine Revenue by Application (2025-2030) & (US$ Million)
    Table 69. Europe Osteoarthritis Pain Medicine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 70. Europe Osteoarthritis Pain Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 71. Europe Osteoarthritis Pain Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 72. Europe Osteoarthritis Pain Medicine Sales by Country (2019-2024) & (K Units)
    Table 73. Europe Osteoarthritis Pain Medicine Sales by Country (2025-2030) & (K Units)
    Table 74. China Osteoarthritis Pain Medicine Sales by Type (2019-2024) & (K Units)
    Table 75. China Osteoarthritis Pain Medicine Sales by Type (2025-2030) & (K Units)
    Table 76. China Osteoarthritis Pain Medicine Revenue by Type (2019-2024) & (US$ Million)
    Table 77. China Osteoarthritis Pain Medicine Revenue by Type (2025-2030) & (US$ Million)
    Table 78. China Osteoarthritis Pain Medicine Sales by Application (2019-2024) & (K Units)
    Table 79. China Osteoarthritis Pain Medicine Sales by Application (2025-2030) & (K Units)
    Table 80. China Osteoarthritis Pain Medicine Revenue by Application (2019-2024) & (US$ Million)
    Table 81. China Osteoarthritis Pain Medicine Revenue by Application (2025-2030) & (US$ Million)
    Table 82. Asia Osteoarthritis Pain Medicine Sales by Type (2019-2024) & (K Units)
    Table 83. Asia Osteoarthritis Pain Medicine Sales by Type (2025-2030) & (K Units)
    Table 84. Asia Osteoarthritis Pain Medicine Revenue by Type (2019-2024) & (US$ Million)
    Table 85. Asia Osteoarthritis Pain Medicine Revenue by Type (2025-2030) & (US$ Million)
    Table 86. Asia Osteoarthritis Pain Medicine Sales by Application (2019-2024) & (K Units)
    Table 87. Asia Osteoarthritis Pain Medicine Sales by Application (2025-2030) & (K Units)
    Table 88. Asia Osteoarthritis Pain Medicine Revenue by Application (2019-2024) & (US$ Million)
    Table 89. Asia Osteoarthritis Pain Medicine Revenue by Application (2025-2030) & (US$ Million)
    Table 90. Asia Osteoarthritis Pain Medicine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 91. Asia Osteoarthritis Pain Medicine Revenue by Region (2019-2024) & (US$ Million)
    Table 92. Asia Osteoarthritis Pain Medicine Revenue by Region (2025-2030) & (US$ Million)
    Table 93. Asia Osteoarthritis Pain Medicine Sales by Region (2019-2024) & (K Units)
    Table 94. Asia Osteoarthritis Pain Medicine Sales by Region (2025-2030) & (K Units)
    Table 95. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Sales by Type (2019-2024) & (K Units)
    Table 96. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Sales by Type (2025-2030) & (K Units)
    Table 97. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Revenue by Type (2019-2024) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Revenue by Type (2025-2030) & (US$ Million)
    Table 99. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Sales by Application (2019-2024) & (K Units)
    Table 100. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Sales by Application (2025-2030) & (K Units)
    Table 101. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Revenue by Application (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Revenue by Application (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 104. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Revenue by Country (2019-2024) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Revenue by Country (2025-2030) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Sales by Country (2019-2024) & (K Units)
    Table 107. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Sales by Country (2025-2030) & (K Units)
    Table 108. Pfizer Company Information
    Table 109. Pfizer Description and Major Businesses
    Table 110. Pfizer Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 111. Pfizer Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Pfizer Recent Developments
    Table 113. Johnson and Johnson Company Information
    Table 114. Johnson and Johnson Description and Major Businesses
    Table 115. Johnson and Johnson Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 116. Johnson and Johnson Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Johnson and Johnson Recent Developments
    Table 118. GlaxoSmithKline Company Information
    Table 119. GlaxoSmithKline Description and Major Businesses
    Table 120. GlaxoSmithKline Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 121. GlaxoSmithKline Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. GlaxoSmithKline Recent Developments
    Table 123. Bayer Company Information
    Table 124. Bayer Description and Major Businesses
    Table 125. Bayer Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 126. Bayer Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Bayer Recent Developments
    Table 128. Eli Lilly Company Information
    Table 129. Eli Lilly Description and Major Businesses
    Table 130. Eli Lilly Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 131. Eli Lilly Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Eli Lilly Recent Developments
    Table 133. Novartis Company Information
    Table 134. Novartis Description and Major Businesses
    Table 135. Novartis Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 136. Novartis Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Novartis Recent Developments
    Table 138. Sanofi Company Information
    Table 139. Sanofi Description and Major Businesses
    Table 140. Sanofi Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 141. Sanofi Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Sanofi Recent Developments
    Table 143. Horizon Pharma Company Information
    Table 144. Horizon Pharma Description and Major Businesses
    Table 145. Horizon Pharma Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 146. Horizon Pharma Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Horizon Pharma Recent Developments
    Table 148. Abbott Company Information
    Table 149. Abbott Description and Major Businesses
    Table 150. Abbott Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 151. Abbott Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Abbott Recent Developments
    Table 153. Mylan Company Information
    Table 154. Mylan Description and Major Businesses
    Table 155. Mylan Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 156. Mylan Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Mylan Recent Developments
    Table 158. Daiichi Sankyo Company Information
    Table 159. Daiichi Sankyo Description and Major Businesses
    Table 160. Daiichi Sankyo Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 161. Daiichi Sankyo Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 162. Daiichi Sankyo Recent Developments
    Table 163. TEVA Company Information
    Table 164. TEVA Description and Major Businesses
    Table 165. TEVA Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 166. TEVA Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 167. TEVA Recent Developments
    Table 168. Almatica Pharma Company Information
    Table 169. Almatica Pharma Description and Major Businesses
    Table 170. Almatica Pharma Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 171. Almatica Pharma Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 172. Almatica Pharma Recent Developments
    Table 173. Astellas Pharma Company Information
    Table 174. Astellas Pharma Description and Major Businesses
    Table 175. Astellas Pharma Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 176. Astellas Pharma Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 177. Astellas Pharma Recent Developments
    Table 178. Tide Pharmaceutical Company Information
    Table 179. Tide Pharmaceutical Description and Major Businesses
    Table 180. Tide Pharmaceutical Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 181. Tide Pharmaceutical Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 182. Tide Pharmaceutical Recent Developments
    Table 183. Iroko Pharmaceuticals Company Information
    Table 184. Iroko Pharmaceuticals Description and Major Businesses
    Table 185. Iroko Pharmaceuticals Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 186. Iroko Pharmaceuticals Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 187. Iroko Pharmaceuticals Recent Developments
    Table 188. Hengrui Pharmaceutical Company Information
    Table 189. Hengrui Pharmaceutical Description and Major Businesses
    Table 190. Hengrui Pharmaceutical Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 191. Hengrui Pharmaceutical Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 192. Hengrui Pharmaceutical Recent Developments
    Table 193. Abiogen Pharma Company Information
    Table 194. Abiogen Pharma Description and Major Businesses
    Table 195. Abiogen Pharma Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 196. Abiogen Pharma Osteoarthritis Pain Medicine Product Model Numbers, Pictures, Descriptions and Specifications
    Table 197. Abiogen Pharma Recent Developments
    Table 198. Key Raw Materials Lists
    Table 199. Raw Materials Key Suppliers Lists
    Table 200. Osteoarthritis Pain Medicine Distributors List
    Table 201. Osteoarthritis Pain Medicine Customers List
    Table 202. Osteoarthritis Pain Medicine Market Trends
    Table 203. Osteoarthritis Pain Medicine Market Drivers
    Table 204. Osteoarthritis Pain Medicine Market Challenges
    Table 205. Osteoarthritis Pain Medicine Market Restraints
    Table 206. Research Programs/Design for This Report
    Table 207. Key Data Information from Secondary Sources
    Table 208. Key Data Information from Primary Sources
List of Figures
    Figure 1. Osteoarthritis Pain Medicine Product Picture
    Figure 2. Global Osteoarthritis Pain Medicine Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Osteoarthritis Pain Medicine Market Share by Type in 2023 & 2030
    Figure 4. Oral Product Picture
    Figure 5. Injection Product Picture
    Figure 6. External Product Picture
    Figure 7. Global Osteoarthritis Pain Medicine Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Osteoarthritis Pain Medicine Market Share by Application in 2023 & 2030
    Figure 9. Medical Care
    Figure 10. Personal Care
    Figure 11. Osteoarthritis Pain Medicine Report Years Considered
    Figure 12. Global Osteoarthritis Pain Medicine Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 13. Global Osteoarthritis Pain Medicine Revenue 2019-2030 (US$ Million)
    Figure 14. Global Osteoarthritis Pain Medicine Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 15. Global Osteoarthritis Pain Medicine Revenue Market Share by Region (2019-2030)
    Figure 16. Global Osteoarthritis Pain Medicine Sales 2019-2030 ((K Units)
    Figure 17. Global Osteoarthritis Pain Medicine Sales Market Share by Region (2019-2030)
    Figure 18. US & Canada Osteoarthritis Pain Medicine Sales YoY (2019-2030) & (K Units)
    Figure 19. US & Canada Osteoarthritis Pain Medicine Revenue YoY (2019-2030) & (US$ Million)
    Figure 20. Europe Osteoarthritis Pain Medicine Sales YoY (2019-2030) & (K Units)
    Figure 21. Europe Osteoarthritis Pain Medicine Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. China Osteoarthritis Pain Medicine Sales YoY (2019-2030) & (K Units)
    Figure 23. China Osteoarthritis Pain Medicine Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. Asia (excluding China) Osteoarthritis Pain Medicine Sales YoY (2019-2030) & (K Units)
    Figure 25. Asia (excluding China) Osteoarthritis Pain Medicine Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Sales YoY (2019-2030) & (K Units)
    Figure 27. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. The Osteoarthritis Pain Medicine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 29. The Top 5 and 10 Largest Manufacturers of Osteoarthritis Pain Medicine in the World: Market Share by Osteoarthritis Pain Medicine Revenue in 2023
    Figure 30. Global Osteoarthritis Pain Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 31. Global Osteoarthritis Pain Medicine Sales Market Share by Type (2019-2030)
    Figure 32. Global Osteoarthritis Pain Medicine Revenue Market Share by Type (2019-2030)
    Figure 33. Global Osteoarthritis Pain Medicine Sales Market Share by Application (2019-2030)
    Figure 34. Global Osteoarthritis Pain Medicine Revenue Market Share by Application (2019-2030)
    Figure 35. US & Canada Osteoarthritis Pain Medicine Sales Market Share by Type (2019-2030)
    Figure 36. US & Canada Osteoarthritis Pain Medicine Revenue Market Share by Type (2019-2030)
    Figure 37. US & Canada Osteoarthritis Pain Medicine Sales Market Share by Application (2019-2030)
    Figure 38. US & Canada Osteoarthritis Pain Medicine Revenue Market Share by Application (2019-2030)
    Figure 39. US & Canada Osteoarthritis Pain Medicine Revenue Share by Country (2019-2030)
    Figure 40. US & Canada Osteoarthritis Pain Medicine Sales Share by Country (2019-2030)
    Figure 41. U.S. Osteoarthritis Pain Medicine Revenue (2019-2030) & (US$ Million)
    Figure 42. Canada Osteoarthritis Pain Medicine Revenue (2019-2030) & (US$ Million)
    Figure 43. Europe Osteoarthritis Pain Medicine Sales Market Share by Type (2019-2030)
    Figure 44. Europe Osteoarthritis Pain Medicine Revenue Market Share by Type (2019-2030)
    Figure 45. Europe Osteoarthritis Pain Medicine Sales Market Share by Application (2019-2030)
    Figure 46. Europe Osteoarthritis Pain Medicine Revenue Market Share by Application (2019-2030)
    Figure 47. Europe Osteoarthritis Pain Medicine Revenue Share by Country (2019-2030)
    Figure 48. Europe Osteoarthritis Pain Medicine Sales Share by Country (2019-2030)
    Figure 49. Germany Osteoarthritis Pain Medicine Revenue (2019-2030) & (US$ Million)
    Figure 50. France Osteoarthritis Pain Medicine Revenue (2019-2030) & (US$ Million)
    Figure 51. U.K. Osteoarthritis Pain Medicine Revenue (2019-2030) & (US$ Million)
    Figure 52. Italy Osteoarthritis Pain Medicine Revenue (2019-2030) & (US$ Million)
    Figure 53. Russia Osteoarthritis Pain Medicine Revenue (2019-2030) & (US$ Million)
    Figure 54. China Osteoarthritis Pain Medicine Sales Market Share by Type (2019-2030)
    Figure 55. China Osteoarthritis Pain Medicine Revenue Market Share by Type (2019-2030)
    Figure 56. China Osteoarthritis Pain Medicine Sales Market Share by Application (2019-2030)
    Figure 57. China Osteoarthritis Pain Medicine Revenue Market Share by Application (2019-2030)
    Figure 58. Asia Osteoarthritis Pain Medicine Sales Market Share by Type (2019-2030)
    Figure 59. Asia Osteoarthritis Pain Medicine Revenue Market Share by Type (2019-2030)
    Figure 60. Asia Osteoarthritis Pain Medicine Sales Market Share by Application (2019-2030)
    Figure 61. Asia Osteoarthritis Pain Medicine Revenue Market Share by Application (2019-2030)
    Figure 62. Asia Osteoarthritis Pain Medicine Revenue Share by Region (2019-2030)
    Figure 63. Asia Osteoarthritis Pain Medicine Sales Share by Region (2019-2030)
    Figure 64. Japan Osteoarthritis Pain Medicine Revenue (2019-2030) & (US$ Million)
    Figure 65. South Korea Osteoarthritis Pain Medicine Revenue (2019-2030) & (US$ Million)
    Figure 66. China Taiwan Osteoarthritis Pain Medicine Revenue (2019-2030) & (US$ Million)
    Figure 67. Southeast Asia Osteoarthritis Pain Medicine Revenue (2019-2030) & (US$ Million)
    Figure 68. India Osteoarthritis Pain Medicine Revenue (2019-2030) & (US$ Million)
    Figure 69. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Sales Market Share by Type (2019-2030)
    Figure 70. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Revenue Market Share by Type (2019-2030)
    Figure 71. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Sales Market Share by Application (2019-2030)
    Figure 72. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Revenue Market Share by Application (2019-2030)
    Figure 73. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Revenue Share by Country (2019-2030)
    Figure 74. Middle East, Africa and Latin America Osteoarthritis Pain Medicine Sales Share by Country (2019-2030)
    Figure 75. Brazil Osteoarthritis Pain Medicine Revenue (2019-2030) & (US$ Million)
    Figure 76. Mexico Osteoarthritis Pain Medicine Revenue (2019-2030) & (US$ Million)
    Figure 77. Turkey Osteoarthritis Pain Medicine Revenue (2019-2030) & (US$ Million)
    Figure 78. Israel Osteoarthritis Pain Medicine Revenue (2019-2030) & (US$ Million)
    Figure 79. GCC Countries Osteoarthritis Pain Medicine Revenue (2019-2030) & (US$ Million)
    Figure 80. Osteoarthritis Pain Medicine Value Chain
    Figure 81. Osteoarthritis Pain Medicine Production Process
    Figure 82. Channels of Distribution
    Figure 83. Distributors Profiles
    Figure 84. Bottom-up and Top-down Approaches for This Report
    Figure 85. Data Triangulation
    Figure 86. Key Executives Interviewed

以下、関連資料のご紹介